Evidence map›Paper›PMID 35946401›Full record

ArticleCirculation research2022

Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank.

Jordana B Cohen, Gary F Mitchell, Dipender Gill, Stephen Burgess, Mahboob Rahman, Thomas C Hanff, Vasan S Ramachandran, Karen M Mutalik, Raymond R Townsend, Julio A Chirinos

Open access · hybridAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Histamine in Diabetic Cardiovascular Complications.Reviews in cardiovascular medicine · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Environment & health (Washington, D.C.) · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Jordana B CohenRenal-Electrolyte and Hypertension Division (J.B.C., R.R.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0003-4649-079X
Gary F MitchellCardiovascular Engineering, Inc, Norwood, MA (G.F.M.).ORCID 0000-0001-5643-3145
Dipender GillDepartment of Epidemiology and Biostatistics, School of Public Health, MRC Centre for Environment and Health, Imperial College London, United Kingdom (D.G.).ORCID 0000-0001-7312-7078
Stephen BurgessMedical Research Council Biostatistics Unit, School of Clinical Medicine (S.B.), University of Cambridge, United Kingdom.ORCID 0000-0001-5365-8760
Mahboob RahmanDepartment of Medicine, Case Western University, University Hospitals Case Medical Center, Cleveland, OH (M.R.).ORCID 0000-0001-9025-7413
Thomas C HanffDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City (T.C.H.).ORCID 0000-0003-3096-1227
Vasan S RamachandranDepartment of Medicine, Boston University School of Medicine, MA (V.S.R.).ORCID 0000-0001-7357-5970
Karen M MutalikFramingham Heart Study, Framingham, MA (V.S.R., K.M.M.).
Raymond R TownsendRenal-Electrolyte and Hypertension Division (J.B.C., R.R.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0002-3215-9118
Julio A ChirinosDivision of Cardiology (J.A.C.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0001-9035-5670
University of Pennsylvania · USBoston University · USFramingham Heart Study · USImperial College London · GBMitchell College · USUniversity Hospitals Cleveland Medical Center · USUniversity of Cambridge · GBUniversity of Utah · US

Funding

Scientific and Data Coordinating Center(SDCC) for the P*U01DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2001 to 2017
$50.1M
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)R01AG058969 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Timothy M. Hughes, YONGMEI LIU · 2018 to 2026
$33.4M
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Understanding the relationship between obesity and tongue fat in humans and ratsP01HL094307 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PACK, ALLAN I · 2009 to 2020
$23.7M
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BPR01HL104106 · NHLBI · UNIVERSITY OF DELAWARE · PI EDWARDS, DAVID G, FARQUHAR, WILLIAM B · 2011 to 2021
$4.5M
Framingham: Inflammation, Genes &Cardiovascular DiseaseR01HL076784 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2004 to 2008
$3.9M
Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEFR01HL155599 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ZAMANI, PAYMAN · 2021 to 2025
$3.9M
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 SurvivorsR01HL157108 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI JULIO ALONSO CHIRINOS MEDINA, Jordana B. Cohen · 2022 to 2026
$3.9M
Home Blood Pressure in Hemodialysis (HOME-BP)R01DK123104 · NIDDK · UNIVERSITY OF WASHINGTON · PI BANSAL, NISHA, HSU, CHI-YUAN · 2021 to 2025
$3.8M
Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEFR01HL157264 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ZAMANI, PAYMAN · 2021 to 2025
$3.5M
Ventricular Vascular Coupling: Correlates and PrognosisR01HL080124 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2005 to 2009
$3.4M
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00002/7Medical Research Council MR/S019669/1NCATS NIH HHS U01 TR003734NHLBI NIH HHS 75N92019D00031NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS K23 HL133843NHLBI NIH HHS N01 HC025195NHLBI NIH HHS P01 HL094307NHLBI NIH HHS R01 HL060040NHLBI NIH HHS R01 HL070100NHLBI NIH HHS R01 HL071039NHLBI NIH HHS R01 HL076784NHLBI NIH HHS R01 HL077447NHLBI NIH HHS R01 HL080124NHLBI NIH HHS R01 HL104106NHLBI NIH HHS R01 HL121510NHLBI NIH HHS R01 HL126136NHLBI NIH HHS R01 HL142983NHLBI NIH HHS R01 HL153646NHLBI NIH HHS R01 HL155599NHLBI NIH HHS R01 HL157108NHLBI NIH HHS R01 HL157264NHLBI NIH HHS R03 HL146874NHLBI NIH HHS R33 HL146390NHLBI NIH HHS R56 HL136730NHLBI NIH HHS U01 HL160277NIA NIH HHS K24 AG070459NIA NIH HHS R01 AG028321NIA NIH HHS R01 AG058969NIA NIH HHS R01 AG074989NIDDK NIH HHS R01 DK123104NIDDK NIH HHS U01 DK060990NIDDK NIH HHS U24 DK060990Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

backgroundMicrovascular damage from large artery stiffness (LAS) in pancreatic, hepatic, and skeletal muscles may affect glucose homeostasis. Our goal was to evaluate the association between LAS and the risk of type 2 diabetes using prospectively collected, carefully phenotyped measurements of LAS as well as Mendelian randomization analyses.

methodsCarotid-femoral pulse wave velocity (CF-PWV) and brachial and central pulse pressure were measured in 5676 participants of the FHS (Framingham Heart Study) without diabetes. We used Cox proportional hazards regression to evaluate the association of CF-PWV and pulse pressure with incident diabetes. We subsequently performed 2-sample Mendelian randomization analyses evaluating the associations of genetically predicted brachial pulse pressure with type 2 diabetes in the UKBB (United Kingdom Biobank).

resultsIn FHS, individuals with higher CF-PWV were older, more often male, and had higher body mass index and mean arterial pressure compared to those with lower CF-PWV. After a median follow-up of 7 years, CF-PWV and central pulse pressure were associated with an increased risk of new-onset diabetes (per SD increase, multivariable-adjusted CF-PWV hazard ratio, 1.36 [95% CI, 1.03-1.76];

conclusionsUsing prospective cohort data coupled with Mendelian randomization analyses, we found evidence supporting that greater LAS is associated with increased risk of developing diabetes. LAS may play an important role in glucose homeostasis and may serve as a useful marker of future diabetes risk.

Indexed as

Diabetes Mellitus, Type 2Vascular StiffnessBiological Specimen BanksBrachial ArteryGlucoseHumansLongitudinal StudiesMaleProspective StudiesPulse Wave AnalysisGlucoseblood pressurecarotid-femoral pulse wave velocityhemodynamicshuman geneticsvascular stiffness

Identifiers

PMID35946401
PMCPMC7613487
OpenAlexW4292661294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.